Biotron Completes Enrolment in Phase 2 Hepatits C Trial of BIT225 3 December 20143 December 2014 by Justine Bednorz Biotron Completes Enrolment in Phase 2 Hepatitis C Trial of BIT225
Results of Annual General Meeting 13 November 2014 by Justine Bednorz Results of Annual General Meeting
Presentation to Annual General Meeting 13 November 2014 by Justine Bednorz Presentation to Annual General Meeting
Fully Underwritten $4.06 Million Rights Issue Closes Oversubscribed 5 November 2014 by Justine Bednorz Fully Underwritten $4.06 Million Rights Issue Closes Oversubscribed
Quarterly Report 30 September 2014 3 November 2014 by Justine Bednorz Quarterly Report 30 September 2014
